Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (1-10 of 321) with videos related to

Pageof 33
Sort By:
Annals of Surgical Oncology|July 21, 2021
The Surgeons' Role When Systemic Therapies Fail in Metastatic Melanoma: The Salvage MetastasectomyJonathan S Zager
Annals of Surgical Oncology|April 29, 2024
ASO Author Reflections: Percutaneous Hepatic Perfusion: Past, Present, and FutureJonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|March 25, 2016
Art, Science, and Personalized Cancer Care Through Regional TherapeuticsKristen Otto, Jonathan S Zager
Annals of Surgical Oncology|June 12, 2025
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal MelanomaJonathan S Zager, Johnny John
Journal of Surgical Oncology|October 30, 2013
Isolated hepatic perfusion for metastatic melanomaMaki Yamamoto, Jonathan S Zager
Expert Opinion on Drug Safety|December 20, 2016
The safety of talimogene laherparepvec for the treatment of advanced melanomaAlexandra Gangi, Jonathan S Zager
Annals of Surgical Oncology|August 21, 2025
Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Johnny John
Annals of Surgical Oncology|October 12, 2021
ASO Author Reflections: T-VEC as Salvage for Progression of Locoregionally Metastatic Melanoma After Failure of ImmunotherapyMichael J Carr, Jonathan S Zager
Surgical Oncology Clinics of North America|February 28, 2012
Isolated regional therapy for advanced extremity soft tissue sarcomasJeremiah L Deneve, Jonathan S Zager
Expert Opinion on Pharmacotherapy|December 17, 2009
Commentary on pharmacotherapy of regional melanoma therapyJonathan S Zager, Keith A Delman
Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:
Pageof 33
Annals of Surgical Oncology|July 21, 2021
The Surgeons' Role When Systemic Therapies Fail in Metastatic Melanoma: The Salvage MetastasectomyJonathan S Zager
Annals of Surgical Oncology|April 29, 2024
ASO Author Reflections: Percutaneous Hepatic Perfusion: Past, Present, and FutureJonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|March 25, 2016
Art, Science, and Personalized Cancer Care Through Regional TherapeuticsKristen Otto, Jonathan S Zager
Annals of Surgical Oncology|June 12, 2025
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal MelanomaJonathan S Zager, Johnny John
Journal of Surgical Oncology|October 30, 2013
Isolated hepatic perfusion for metastatic melanomaMaki Yamamoto, Jonathan S Zager
Expert Opinion on Drug Safety|December 20, 2016
The safety of talimogene laherparepvec for the treatment of advanced melanomaAlexandra Gangi, Jonathan S Zager
Annals of Surgical Oncology|August 21, 2025
Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Johnny John
Annals of Surgical Oncology|October 12, 2021
ASO Author Reflections: T-VEC as Salvage for Progression of Locoregionally Metastatic Melanoma After Failure of ImmunotherapyMichael J Carr, Jonathan S Zager
Surgical Oncology Clinics of North America|February 28, 2012
Isolated regional therapy for advanced extremity soft tissue sarcomasJeremiah L Deneve, Jonathan S Zager
Expert Opinion on Pharmacotherapy|December 17, 2009
Commentary on pharmacotherapy of regional melanoma therapyJonathan S Zager, Keith A Delman
Pageof 33